MPM BioImpact LLC
MPM BioImpact LLC reported 37 positions worth $1.64B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: CGEM (10.8%).
| # | Symbol | Company | Type | Value ↓ | % Port. | Shares | 1Y | YTD |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | CGEM | SH | $177.2M | 10.81% | 9,731,341 | — | — | |
| ▸ 2 | AKTS | SH | $155.9M | 9.50% | 4,835,872 | — | — | |
| ▸ 3 | LQDA | SH | $110.5M | 6.74% | 1,386,174 | — | — | |
| ▸ 4 | RVMD | SH | $92.2M | 5.62% | 492,483 | — | — | |
| ▸ 5 | CORT | SH | $67.0M | 4.09% | 771,028 | — | — | |
| ▸ 6 | EWTX | SH | $65.9M | 4.02% | 1,620,780 | — | — | |
| ▸ 7 | TVTX | SH | $63.8M | 3.89% | 1,122,731 | — | — | |
| ▸ 8 | DBVT | SH | $60.1M | 3.67% | 3,666,284 | — | — | |
| ▸ 9 | TRVI | SH | $57.3M | 3.50% | 3,073,577 | — | — | |
| ▸ 10 | ALMS | SH | $56.8M | 3.46% | 2,019,020 | — | — |
The free plan shows the top 10 positions. The remaining 27 positions, the full portfolio and quarter changes unlock with Pro.
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProRead the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does MPM BioImpact LLC hold as of Q2 2026?
MPM BioImpact LLC reported 37 positions worth $1.64B in its Q2 2026 13F filing. Largest positions: CGEM (10.8%), AKTS (9.5%), LQDA (6.7%), RVMD (5.6%) and CORT (4.1%).
What did MPM BioImpact LLC buy in Q2 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did MPM BioImpact LLC sell in Q2 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.